Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment
https://pixabay.com/en/excited-smiling-female-college-1280963/

Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment

In April, Prometic Life Sciences Inc. announced it would be submitting a Biologics License Application to the FDA for treatment of hypoplasminogenemia. The company's therapy has already been listed with Orphan…

Continue Reading Application Recently Submitted to FDA for New Hypoplasminogenemia Treatment